Salivary level of interleukin-17 in patients having atrophic and erosive oral lichen planus before and after treatment with topical steroids (A Controlled clinical trial) - Egyptian Knowledge Bank - troweb

140318

Salivary level of interleukin-17 in patients having atrophic and erosive oral lichen planus before and after treatment with topical steroids (A Controlled clinical trial)

Article

Last updated: 22 Jan 2023

Overview Similar Items

Article

Assessment of IL-17 in Oral Lichen Planus and in Pemphigus Vulgaris

Article

Salivary Levels of Soluble Fas in Oral Lichen Planus Patients Before and After Treatment with Topical Corticosteroids

Article

EVALUATION OF THE POSSIBLE ROLE OF IL-17 AND ITS RECEPTOR IL-17R IN THE PATHOGENESIS OF ORAL LICHEN PLANUS

Article

INTERLEUKIN 23 AND INTERLEUKIN17 IN PSORIASIS, ATOPIC DERMATITIS AND LICHEN PLANUS: A SEROLOGICAL STUDY

Article

ESTIMATION OF SALIVARY TUMOR NECROISIS FACTOR-ALPHA LEVEL IN PATIENTS WITH EROSIVE ORAL LICHEN PLANUS (A CASE CONTROL STUDY)

Article

Effect of topical steroid therapy of bullous erosive lichen planus on serum and salivary levels of advanced glyacation end products

Article

salivary calprotectin level in patients with oral lichen planus

Article

INCREASED SALIVARY AND SERUM LEVELS OF IL-33 IN PATIENTS WITH ORAL PEMPHIGUS VULGARIS

Article

Immunohistochemical study of nuclear factor kappa-light chain enhancer of activated B cells (NF-KB) and interleukin-17 (IL-17) in oral lichen planus

Article

Photodynamic therapy and topical steroid effects upon immune regulatory cells among patients with oral lichen planus